M. Hetland

发表

Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis

K. Stengaard-Pedersen, P. Junker, K. Hørslev-Petersen, 2022, Scandinavian journal of rheumatology.

Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial

C. Brahe, K. Stengaard-Pedersen, T. Ellingsen, 2018, Scandinavian journal of rheumatology.

Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA tria

C. Brahe, K. Stengaard-Pedersen, T. Ellingsen, 2018, Scandinavian journal of rheumatology.

Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial

H. Bliddal, M. Østergaard, K. Stengaard-Pedersen, 2021, Scandinavian journal of rheumatology.

Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.

K. Stengaard-Pedersen, P. Junker, K. Hørslev-Petersen, 2022, Scandinavian journal of rheumatology.

Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent

M. Østergaard, T. Kvien, T. Kvien, 2005, Annals of the rheumatic diseases.

Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database

M. Østergaard, U. Tarp, M. Østergaard, 2007, Scandinavian journal of rheumatology.

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010–2016: a collaboration between five biological registries

S. Provan, J. Askling, S. Ernestam, 2018, Scandinavian journal of rheumatology.

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

B. Glintborg, M. Hetland, S. Chrysidis, 2017 .

FRI0607 Effect of Methotrexate and Intra-Articular Betamethasone with or Without Additional Cyclosporine on Magnetic Resonance Imaging (MRI)-Determined Inflammatory and Destructive Changes in Very Early Rheumatoid Arthritis – Results from a 24-Months' Randomised Double Blind Placebo Controlled Trial

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2015 .

Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis

K. Stengaard-Pedersen, B. Deleuran, K. Hørslev-Petersen, 2014, Scandinavian journal of rheumatology.

Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

M. Østergaard, K. Stengaard-Pedersen, T. Ellingsen, 2015, Annals of the rheumatic diseases.

Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration

K. Pavelka, S. Saevarsdottir, H. Canhão, 2018, Scandinavian journal of rheumatology.

Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2014, Scandinavian journal of rheumatology.

FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

Helena Canhão, Xavier Mariette, C. Turesson, 2014 .

Abstracts of the 34th Scandinavian Congress of Rheumatology, Copenhagen, Denmark, September 2nd – 5th, 2012

A. Thormann, N. Graudal, B. Glintborg, 2012, Scandinavian journal of rheumatology. Supplement.

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis

K. Stengaard-Pedersen, H. C. Horn, T. Ellingsen, 2015, The Pharmacogenomics Journal.

Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years’ functional and radiographic outcome in early rheumatoid arthritis

K. Stengaard-Pedersen, T. Ellingsen, P. Junker, 2018, Scandinavian journal of rheumatology.

Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2015, Scandinavian journal of rheumatology.

Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients

K. Stengaard-Pedersen, H. Glerup, P. Junker, 2017, Scandinavian journal of rheumatology.

Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging

H. Bliddal, M. Østergaard, O. Kubassova, 2014, Scandinavian Journal of Rheumatology.

Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis

C. Turesson, X. Mariette, K. Pavelka, 2016 .

Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure

A. Boonen, M. Østergaard, O. Madsen, 2008, Annals of the rheumatic diseases.

Interleukin-23 in early disease development in rheumatoid arthritis

M. Østergaard, K. Stengaard-Pedersen, P. Junker, 2015, Scandinavian journal of rheumatology.

Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis

B. Glintborg, M. Østergaard, S. Krabbe, 2018, Scandinavian journal of rheumatology.

Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study

M. Nørgaard, A. Petersen, F. Mehnert, 2022, Scandinavian journal of rheumatology.

Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias

A. Tennant, M. Hetland, L. Ørnbjerg, 2020, Scandinavian journal of rheumatology.

Galectin‐3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti‐CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity

K. Stengaard-Pedersen, P. Junker, U. Tarp, 2017, Scandinavian journal of immunology.

OP0210 PREGNANCY OUTCOMES IN RELATION TO DISEASE ACTIVITY AND ANTI-RHEUMATIC TREATMENT STRATEGIES IN WOMEN WITH RHEUMATOID ARTHRITIS – A MATCHED COHORT STUDY FROM SWEDEN AND DENMARK

F. Granath, K. Hellgren, B. Gudbjornsson, 2021 .

POS1069 SYSTEMATIC LITERATURE REVIEW INFORMING THE EULAR POINTS TO CONSIDER TASK FORCE ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER

A. Regierer, J. Askling, D. Aletaha, 2023, Annals of the Rheumatic Diseases.

OP0045 EULAR POINTS TO CONSIDER ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER

A. Regierer, J. Askling, D. Aletaha, 2023, Annals of the Rheumatic Diseases.

Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients

R. Christensen, B. Glintborg, M. Skougaard, 2018, Scandinavian journal of rheumatology.

FRI0322 Positivity for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide is Associated with A Better Drug Retention of Abatacept: Data from A Paneuropean Analysis of RA Registries

C. Turesson, X. Mariette, K. Pavelka, 2014 .

Characteristics of participants and decliners from a randomized controlled trial on physical activity in patients with rheumatoid arthritis: a retrospective register-based cross-sectional study

M. Aadahl, B. A. Esbensen, T. Thomsen, 2021, Scandinavian journal of rheumatology.